Reflecting on racial disparity in US managed-care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Quality of care deficits threaten public health in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Racial differences in breast cancer survival in a large urban integrated health system

By Roseland Molly E.   Pressler Mary E.   E. Lamerato Lois   Krajenta Rick   Ruterbusch Julie J.   Booza Jason C.   Schwartz Kendra   Simon Michael S.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3668-3675

Blackwell Publishing

Access to resources Recommend Favorite

Janssen, L.P., have issued a `Dear Health Care Professional' letter informing of changes to the US Duragesic [fentanyl transdermal system] label.

By  

Reactions Weekly, Vol. 1, Iss. 1060, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Ailing US health insurance system under the spotlight

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite